The Egyptian Stock Exchange announced that the shares of the pharmaceutical company (Macro Group) will be restricted on the stock exchange, starting today, Thursday.
The stock exchange said in the statement that the listing of Macro Group shares came after the approval of the Securities Listing and Delisting Committee yesterday.
This paves the way for the company to offer up to 45.8% of its shares, which will be traded under the symbol (MCRO.CA) in a deal that puts the company's market value at 3.5 billion EGP, according to what the Financial Supervisory Authority said in a statement last month.
The company had obtained, last month, the green light from the Financial Supervisory Authority to list its shares on the stock exchange, and gave it until late January to implement the offering.
Earlier this week, informed sources said, according to Enterprise, that the company's shares are expected to start trading on the Egyptian Stock Exchange during the first quarter of 2022, noting The timetable for the offering has not yet been determined.
